Target intelligence / Profile preview

PDCL3 pseudogene 4 (PDCL3P4)

Target: PDCL3P4
Molecular classification: Pseudogene, Long noncoding RNA (lncRNA)

Overview

PDCL3 pseudogene 4 (PDCL3P4) is a noncoding RNA derived from a retrotransposed copy of the phosducin-like 3 gene (PDCL3)[1]. It is transcribed from a long terminal repeat (LTR) promoter on chromosome 3 and is highly enriched in the nucleus, suggesting a regulatory role as a lncRNA rather than serving as a protein-coding gene[1]. Experimental knockout in cells results in significant alteration of global gene expression without affecting the expression of the parental PDCL3 gene, indicating that PDCL3P4 functions independently as a regulatory RNA. It exemplifies pseudogene-derived lncRNAs with potential impacts on cellular transcriptomes, but it is not an established drug target or biomarker, and its molecular mechanisms remain under investigation[1].

Other names: PDCL3P4Phosducin-like 3 pseudogene 4

Biological functions

Regulation of gene expression (as a noncoding regulatory RNA, it impacts the transcriptome independent of its parent gene)Nuclear enrichment, possibly acting as a lncRNA

Disease associations

Other (pseudogene; not directly implicated in specific diseases, but its perturbation results in altered expression of hundreds of genes, potentially affecting diverse biological pathways)No established direct disease role of PDCL3P4 itself

Safety considerations

No notable safety concerns are associated with the pseudogene or its manipulation based on current evidence; CRISPR-mediated knockout studies in cell lines showed transcriptome-wide effects but no established clinical safety issues

Beyond the preview

Go deeper on PDCL3 pseudogene 4 (PDCL3P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDCL3 pseudogene 4 (PDCL3P4).

Explore the full profile